Breast cell line dose response to target inhibition measured by high throughput microscopy - Dataset (ID:20136)
Download: Excel (XLSX), Comma-separated (CSV)
| Small Molecule | Cell Line | Drug Concentration | Conc Units | Timepoint | Timepoint Units | Measured pERK (Alexa 488) | Measured p-Rb (Alexa 568) | Alexa Fluor 647 | Measured p-Akt/p-4EBP1/p-S6 (Alexa 647) | Image |
|---|---|---|---|---|---|---|---|---|---|---|
| Gefitinib | T47D | 0 (control) | 24 | hr | 163.37 | 117.01 | p-4EBP1 | 417.96 | | |
| GSK1059615 | T47D | 0 (control) | 6 | hr | 170.99 | 85.49 | p-4EBP1 | 487.39 | | |
| GSK1059615 | T47D | 0 (control) | 24 | hr | 164.30 | 107.15 | p-4EBP1 | 431.40 | | |
| MK2206 | T47D | 0 (control) | 24 | hr | 168.35 | 111.49 | p-4EBP1 | 409.81 | | |
| Triciribine | T47D | 0 (control) | 6 | hr | 91.82 | 35.81 | p-4EBP1 | 108.61 | | |
| Gefitinib | AU565 | 0 (control) | 6 | hr | 226.23 | 50.86 | p-4EBP1 | 51.79 | | |
| Gefitinib | AU565 | 0 (control) | 24 | hr | 597.19 | 141.39 | p-4EBP1 | 180.42 | | |
| Torkinib | AU565 | 0 (control) | 24 | hr | 520.08 | 134.68 | p-4EBP1 | 226.94 | | |
| GSK1059615 | AU565 | 0 (control) | 6 | hr | 234.34 | 56.31 | p-4EBP1 | 61.94 | | |
| MK2206 | AU565 | 0 (control) | 24 | hr | 443.02 | 135.36 | p-4EBP1 | 212.85 | | |
| Triciribine | AU565 | 0 (control) | 6 | hr | 277.93 | 72.56 | p-4EBP1 | 95.48 | | |
| Dactolisib | AU565 | 0 (control) | 6 | hr | 223.15 | 50.37 | p-4EBP1 | 55.92 | | |
| Dactolisib | AU565 | 0 (control) | 24 | hr | 527.81 | 136.32 | p-4EBP1 | 202.58 | | |
| Torkinib | HCC1954 | 0 (control) | 24 | hr | 299.58 | 124.61 | p-4EBP1 | 139.95 | | |
| GSK1059615 | HCC1954 | 0 (control) | 6 | hr | 337.11 | 90.46 | p-4EBP1 | 107.99 | | |
| MK2206 | HCC1954 | 0 (control) | 6 | hr | 142.39 | 29.98 | p-4EBP1 | 49.89 | | |
| MK2206 | HCC1954 | 0 (control) | 24 | hr | 298.17 | 123.52 | p-4EBP1 | 156.31 | | |
| Dactolisib | HCC1954 | 0 (control) | 6 | hr | 182.86 | 43.74 | p-4EBP1 | 53.60 | | |
| Dactolisib | HCC1954 | 0 (control) | 24 | hr | 323.44 | 115.77 | p-4EBP1 | 138.95 | | |
| Gefitinib | MCF 10A | 0 (control) | 24 | hr | 372.82 | 142.63 | p-4EBP1 | 369.21 | | |
| Torkinib | MCF 10A | 0 (control) | 6 | hr | 502.64 | 155.63 | p-4EBP1 | 400.80 | | |
| MK2206 | MCF 10A | 0 (control) | 24 | hr | 340.91 | 138.48 | p-4EBP1 | 378.35 | | |
| Triciribine | MCF 10A | 0 (control) | 6 | hr | 451.41 | 160.21 | p-4EBP1 | 412.08 | | |
| Gefitinib | AU565 | 1.0 | nM | 24 | hr | 597.04 | 145.45 | p-4EBP1 | 170.31 | |
| Gefitinib | AU565 | 1.0 | nM | 6 | hr | 289.01 | 63.74 | p-4EBP1 | 68.42 | |